Medscape
The US Food and Drug Administration (FDA) has approved treosulfan (Grafapex, Medexus Pharmaceuticals) in combination with fludarabine as a preparative regimen to clear bone marrow before allogeneic hematopoietic stem cell transplant in adults and children with acute myeloid leukemia or myelodysplastic syndromes who are at increased risk for adverse events with standard conditioning regimens. …
Read More
FDA Approves Grafapex (Treosulfan) for HSCT Conditioning
Leigha Mayoral
14:21
The US Food and Drug Administration (FDA) has approved treosulfan (Grafapex, Medexus Pharmaceuticals) in combination with fludarabine as a preparative regimen to clear bone marrow before allogeneic hematopoietic stem cell transplant in adults and children with acute myeloid leukemia or myelodysplastic syndromes who are at increased risk for adverse events with standard conditioning regimens. …
